MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 161 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $909,245 | -39.7% | 6,226 | -4.6% | 0.00% | -33.3% |
| Q2 2023 | $1,507,737 | -6.8% | 6,527 | -2.3% | 0.00% | -25.0% |
| Q1 2023 | $1,618,539 | +195.8% | 6,681 | +254.4% | 0.00% | +300.0% |
| Q4 2022 | $547,121 | -2.1% | 1,885 | -62.0% | 0.00% | 0.0% |
| Q4 2018 | $559,000 | -62.9% | 4,955 | -29.6% | 0.00% | 0.0% |
| Q3 2018 | $1,508,000 | -54.3% | 7,041 | -40.3% | 0.00% | -66.7% |
| Q2 2018 | $3,298,000 | +392.2% | 11,790 | +105.5% | 0.00% | +200.0% |
| Q1 2018 | $670,000 | – | 5,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |